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Abstract: The complex relationship between adenosine, obesity and Type 2 Diabetes (T2D) prompted us to investigate 
a possible role of genetic variability within adenosine deaminase (ADA) gene in the susceptibility to T2D in obese 
subjects.  With enzymatic activity ADA contributes to the regulation of adenosine concentration in body fluids and as 
ecto- enzyme modulates signaling events involving adenosine receptors on cell surface. 
Three polymorphic sites within the ADA gene, ADA1 (exon 1), ADA2 (intron 2) and ADA6 (exon6) were examined in 299 
subjects from the White population of Rome admitted to the Hospital for cardiovascular diseases. Each site shows two 
alleles: the alleles with higher frequency are ADA1*1, ADA2*1 and ADA6*2. 
Informed consent was obtained by the patients to participate to the study that was approved by the Council of 
Department.  
For the three sites examined the relative risk of T2D in obese subjects (vs non obese) is higher in carriers of the 
homozygous genotype for the allele with higher frequency. The three loci cooperate to the risk that is low in subjects 
carrying no homozygous genotype (O.R. 1.25) but it is very high (O.R. 13.240) in subjects carrying the three 
homozygous genotypes. 
From a practical point of view, the study of ADA gene may help to detect obese subjects at high risk of T2D who need 
active preventive measures. The results point to the importance of further studies on the role of genetic variability within 
ADA gene on the relationship within obesity and T2D. 
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INTRODUCTION 
Several experimental observations suggest a 
complex relationship among adenosine, obesity and 
type 2 diabetes. An increase of adenosine A1 receptor 
activity is associated with obesity in T2D [1-3] and we 
have found an association between adenosine 
deaminase locus 1 (ADA1) genetic polymorphism and 
Body Mass Index (BMI) in T2D [4]. Adenosine may 
increase the sensitivity to insulin in adipose tissue [5-7] 
and in obese subjects a decrease of A1 receptors 
number has been reported [8]. Adenosine deaminase 
(ADA) controls the irreversible deamination of 
adenosine to inosine contributing to the regulation of 
adenosine concentration in body fluids. 
The biochemical genetic polymorphism of ADA was 
discovered in 1968 by Harris group [9] who identified 
by starch gel electrophoresis three common genotypes 
determined by the presence of two codominant alleles 
ADA1*1 and ADA1*2 at an autosomal locus. ADA1*1 is 
more enzymatically active as compared to ADA1*2. 
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The structure of ADA gene has been elucidated by 
Viginton et al. in 1986 [10]. The gene is localized on 
chromosome 20q13.11 and is composed by 12 exons 
spanning about 32 Kb of DNA. Several polymorphic 
loci have been identified within exonic and intronic 
regions of the gene [11]. The possible relationship 
between this genetic variability and human diseases is 
at present unknown. Besides the enzymatic function in 
deamination of adenosine, ADA acts also as ecto-
enzyme contributing to the degradation of extra cellular 
adenosine and interacting with the anchoring proteins 
CD26 and A1R facilitates signaling events [12, 13]. 
In the present note we have studied the role of ADA 
genetic variability in the relationship between obesity 
and T2D in a sample of subjects admitted to the 
Hospital for cardiovascular diseases. The high 
susceptibility to T2D in obese subjects is well known: 
many obese subjects, however, do not become 
diabetic while non obese subjects may become 
diabetic suggesting that genetic factors have an 
important role in the relationship between obesity and 
diabetes. Indeed we have recently reported an effect of 
p53 codon 72 polymorphism on the susceptibility to 
Type 2 Diabetes in overweight subjects [14]. 
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We have examined three single nucleotide 
polymorphisms (SNPs) within the ADA gene: ADA1 
(Taq 1 site nt 4050-4053) on exon 1 corresponding to 
the biochemical genetic polymorphism described by the 
group of Harris in 1968; ADA2  (Pst 1 site nt 19465-
19470) localized on intron 2 and ADA6 (MluNI site nt 
31230-31235) localized on exon 6. 
MATERIAL AND METHODS 
We have studied 299 subjects from the White 
population of Rome admitted consecutively to the 
Hospital for cardiovascular diseases. These patients 
have been considered also in previous studies [14]. 
Verbal consent was obtained by the patients to 
participate to the study that was approved by the 
council of department. The data have been collected a 
few years ago, before the establishment of an Ethical 
Committee. All procedures followed were in 
accordance with the ethical standards and with the 
Helsinki Declaration of 1964 and its later amendments. 
Genotypes of ADA1, ADA2 and ADA6 were 
determined by DNA analysis as previously described 
[15]. Statistical analyses were performed by 
commercial software (SPSS) [16]. The number of 
subjects is not exactly the same in all tables because of 
random loss of some genotype determination among 
the loci considered. Eta(η) is a measure of the strength 
of association between two variables. Eta squared (η2) 
represents the proportion of variance of dependent 
variable explained by the independent variable. 
RESULTS 
Table 1 shows some demographic data on the 
subjects studied. 
Table 1: Demographic Data on the Subjects Studied 
 Proportion Mean ±S.D. 
Females 47.4%  
Age (years)  66.7±11.6 
BMI  27.4±5.2 
 
Table 2 shows the relative risk to become diabetic 
in obese subjects vs non obese subjects in relation to 
homozygosity for ADA1, ADA2 and ADA6 
polymorphisms. For all ADA sites the relative risk to 
become diabetics is higher in homozygous subjects for 
the more common allele than in carriers of the less 
frequent allele. 
Table 2: The Effect of ADA1, ADA2 and ADA6 Genotypes 
on the Relative Risk of Diabetes in Obese 
Subjects vs Non Obese Subjects. Odds Ratio: 
Diabetes vs non Diabetes / BMI >30 vs BMI ≤ 30 
ADA1 genotypes 
 *1/*1 Carriers of ADA1*2 allele 
N° of subjects 264 35 
O.R. 5.81 3.50 
95% C.I. 2.93 – 11.56 0.51 – 25.32 
η2 0.125 0.066 
ADA2 genotypes 
 *1/*1 Carriers of ADA2*2 allele 
N° of subjects 187 110 
O.R. 8.52 3.28 
95% C.I. 3.66 – 20.06 1.13 – 9.59 
η2 0.184 0.056 
ADA6 genotypes 
 *2/*2 Carriers of ADA6*1 allele 
N° of subjects 192 106 
O.R. 5.91 4.23 
95% C.I. 2.72 – 12.93 1.25 – 14.43 
η2 0.137 0.069 
 
Table 3 shows the relationship between the number 
of homozygous genotypes for the more frequent allele 
in the three ADA loci and the relative risk to become 
diabetics in obese subjects vs non obese subjects. 
Odds ratio and strength of association between obesity 
and T2D increases with the number of homozygous 
genotypes. Three-way contingency table analysis by a 
log linear model shows a statistically significant 
interaction among diabetes, BMI and ADA suggesting 
that the association between obesity and diabetes 
depends on ADA genotype. The analysis also shows a 
significant cooperative effect of ADA and obesity on the 
susceptibility to diabetes: the strength of association 
between ADA and diabetes, however, is lower as 
compared to the strength of association between 
obesity and diabetes. 
We have analyzed the effect of sex and age (≤65 
years’ vs > 65 years) on the relationship between 
genetic variability of ADA gene and susceptibility to 
diabetes in obese subjects Odds Ratio diabetics vs non 
diabetics/ BMI>30 vs BMI ≤ 30 is always higher in 
carriers of homozygous genotypes in the three loci than 
in other subjects. 
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DISCUSSION AND CONCLUSION 
The data suggest a relationship between genetic 
variability within the ADA gene and susceptibility to 
T2D in obese subjects. The susceptibility appears 
negatively correlated with the number of loci in which is 
present the variant with low frequency suggesting an 
heterozygote advantage in the protection of obese 
subjects from diabetes. The mechanism underlying this 
advantage has to be elucidated. If confirmed in other 
clinical settings, our observation could allow to assign a 
higher risk of diabetes to obese subjects who are 
homozygous for the major allele in all the three loci of 
ADA gene. 
ADA1 is an exonic polymorphism associated with 
quantitative variation of enzymatic activity. ADA2 is an 
intronic polymorphism and ADA6 is an exonic 
polymorphism characterized by a synonymous 
substitution, which does not change the protein 
sequence but could influence tissue specific 
expression. ADA2 and ADA6 could be in linkage 
disequilibrium with ADA sites directly responsible for 
the association observed. Indeed the analysis of 
linkage disequilibrium within the ADA gene performed 
by Cruciani et al. [17] has shown areas of weak 
association and areas of strong association between 
pairs of internal markers. 
The correlation between obesity and diabetes is 
stronger in subjects homozygous for the more frequent 
allele in all the three loci examined than in other 
subjects. It is possible that the three loci directly or 
indirectly control different mechanisms involved in the 
susceptibility to diabetes in obese subjects: the 
maximum risk is attained when the three mechanisms 
operate simultaneously. 
Further investigations on the role of ADA in the 
susceptibility to T2D in obese subjects would be 
rewarding. The limitations of our study are represented 
by the relatively small number of subjects examined 
and by the fact that it has been carried out on a sample 
of subjects admitted to the hospital for cardiovascular 
diseases and this could have introduced some non-
identified bias. 
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Table 3: The Relationship between Genetic Variability within the ADA Gene and the Relative Risk of Diabetes in 
Obese vs Non Obese Subjects. For ADA1, ADA2 and ADA6 the More Frequent Alleles are Respectively 
ADA1*1, ADA2*1 and ADA6*2 and the Homozygous Genotypes are ADA1*1/*1, ADA2*1/*1 and ADA6*2/*2 
Number of Homozygous Genotypes for the More Frequent Allele at ADA1, ADA2 and ADA6 Loci 
  0 1 and 2 3 
% proportion of diabetics 16.7% 21.1% 8.9% 
BMI≤ 30  
Total n° 6 128 89 
% proportion of diabetics 20.0% 47.4% 56.7% 
BMI > 30 
Total n° 5 38 30 
Odds Ratio Analysis 
O.R. 
 95% C. I. 
 
1.25 
0.033 - 2.470 
 
3.37 
1.464 – 7.770 
 
13.24 
 4.284 – 42.438 
Chi square test of independence  
Χ2 
df 
P 
η2 
 
0.412 
1 
0.777 
0.04 
 
8.951 
1 
0.004 
0.07 
 
27.928 
1 
<10-6 
0.26 
Three-way contingency table analysis by a log linear model (for this analysis class 0 has been joined with class 1+2) 
x=ADA; y=diabetes ; z=BMI                                        G               df           p 
xyz interaction                                                             5.575         1         0.023 
xy independence                                                         7.083         2         0.030 
yz independence                                                       35.977         2     <<0.0001 
Independence of y 
from x and z                                                              37.180         3     <<0.0001 
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